Inotek Pharma (ITEK) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ITEK Hot Sheet
Join SI Premium – FREE
Inotek Pharma (NASDAQ: ITEK) reported Q2 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Inotek Pharma (ITEK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
